Skye Bioscience Inc (SKYE)
5.53
+0.21
(+3.95%)
USD |
NASDAQ |
Nov 14, 16:00
5.53
0.00 (0.00%)
After-Hours: 20:00
Skye Bioscience Market Cap: 167.77M for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 161.40M |
| November 12, 2024 | 163.52M |
| November 11, 2024 | 166.86M |
| November 08, 2024 | 173.23M |
| November 07, 2024 | 165.04M |
| November 06, 2024 | 162.92M |
| November 05, 2024 | 162.31M |
| November 04, 2024 | 165.04M |
| November 01, 2024 | 168.68M |
| October 31, 2024 | 158.97M |
| October 30, 2024 | 154.42M |
| October 29, 2024 | 158.37M |
| October 28, 2024 | 156.24M |
| October 25, 2024 | 152.60M |
| October 24, 2024 | 148.05M |
| October 23, 2024 | 157.76M |
| October 22, 2024 | 149.87M |
| October 21, 2024 | 142.89M |
| October 18, 2024 | 140.47M |
| October 17, 2024 | 128.33M |
| October 16, 2024 | 129.85M |
| October 15, 2024 | 127.42M |
| October 14, 2024 | 124.08M |
| October 11, 2024 | 130.15M |
| October 10, 2024 | 113.47M |
| Date | Value |
|---|---|
| October 09, 2024 | 113.47M |
| October 08, 2024 | 117.41M |
| October 07, 2024 | 116.50M |
| October 04, 2024 | 107.70M |
| October 03, 2024 | 108.61M |
| October 02, 2024 | 108.31M |
| October 01, 2024 | 111.95M |
| September 30, 2024 | 118.62M |
| September 27, 2024 | 113.77M |
| September 26, 2024 | 120.14M |
| September 25, 2024 | 118.02M |
| September 24, 2024 | 121.66M |
| September 23, 2024 | 105.88M |
| September 20, 2024 | 95.26M |
| September 19, 2024 | 166.56M |
| September 18, 2024 | 158.97M |
| September 17, 2024 | 160.19M |
| September 16, 2024 | 175.96M |
| September 13, 2024 | 182.03M |
| September 12, 2024 | 182.03M |
| September 11, 2024 | 192.65M |
| September 10, 2024 | 212.06M |
| September 09, 2024 | 192.65M |
| September 06, 2024 | 177.18M |
| September 05, 2024 | 183.85M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
7.452M
Minimum
Dec 11 2020
487.17M
Maximum
Apr 17 2024
55.21M
Average
24.43M
Median
Market Cap Benchmarks
| Oramed Pharmaceuticals Inc | 94.99M |
| Viking Therapeutics Inc | 5.982B |
| NovaBay Pharmaceuticals Inc | 3.555M |
| Palatin Technologies Inc | 20.92M |
| iBio Inc | 18.83M |
Market Cap Related Metrics
| PS Ratio | 561.37 |
| Price to Book Value | 2.213 |
| Price | 5.53 |
| Earnings Yield | -15.15% |